Product Overview
Drug name: Bai Tang Ping
Generic name: Acarbose tablets
Brand Name: Baitang Ping
Dosage form: tablet
Main ingredients: The main ingredient is acarbose. Chemical name: O-4,6-Dideoxy-4[[(1S,4R,5S,6S)4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexene]amino]- (-D-Glucopyranosyl(1→4)-O-(-D-Glucopyranosyl(1→4)-D-glucopyranosyl(1→4).
Properties: This product is white or light yellow flakes.
Function and indications: Cooperate with diet control to treat type 2 diabetes.
Dosage: Swallow the whole tablet immediately before a meal or chew with the first few mouthfuls of food. The dosage varies from person to person. The general recommended dose is: the starting dose is 50 mg each time, 3 times a day. Gradually increase to 0.1g each time, 3 times a day. In individual cases, it can be increased to 0.2g each time, 3 times a day. Or follow the doctor's advice.
Adverse reactions: Flatulence and bowel sounds are common, diarrhea is occasionally, and abdominal pain is rare. If you do not control your diet, gastrointestinal side effects may increase. If you still have severe symptoms after controlling your diet, you should consult a doctor to reduce the dose temporarily or for a long time. Individual cases may have skin allergic reactions such as erythema, rash, and urticaria.
Taboo: 1. Those who are allergic to acarbose and/or inactive ingredients. 2. In view of the lack of sufficient data on the efficacy and tolerability of this product in children and adolescents, this product should not be used in patients under 18 years of age. 3. Patients with chronic gastrointestinal dysfunction who have obvious digestion and absorption disorders should not be used. 4. Patients with conditions that may worsen due to flatulence (such as ROEMHELD syndrome, severe hernia, intestinal obstruction, and intestinal ulcer) are contraindicated. 5. Patients with severe renal impairment (creatinine clearance 25ML/min) are contraindicated. 6. Because there is no information about the use of this drug in pregnant women, pregnant women should not use this product. 7. After taking radiolabeled acarbose tablets, lactating rats found a small amount of radioactive substances in their milk, and there is no similar discovery in humans. Even so, since the impact of milk acarbose tablets on babies cannot be ruled out, in principle, it is not recommended to use this product in breastfeeding women.
Matters needing attention: 1. The patient should follow the doctor's advice to adjust the dosage. 2. If the patient is not effective after taking the medicine for 4 to 8 weeks, the dose can be increased. If the patient adheres to a strict diabetic diet and is still uncomfortable, the dose cannot be increased, and sometimes the dose needs to be appropriately reduced. The average dose is 0.1G each time, 3 times a day. 3. Individual patients, especially when using high doses, will experience asymptomatic elevation of liver enzymes. Therefore, we should consider monitoring liver enzyme changes during the first 6 to 12 months of medication. However, liver enzyme levels will return to normal after stopping the drug. 4. This product has the effect of anti-hyperglycemia, but it does not cause hypoglycemia by itself. If this product is used with sulfonylurea drugs, metformin or insulin, blood sugar will drop to the level of hypoglycemia, so it is necessary to reduce sulfonylurea The dosage of the drug, metformin or insulin. 5. This product can decompose sucrose into fructose and glucose more slowly. Therefore, if acute hypoglycemia occurs, sucrose should not be used, but glucose should be used to correct hypoglycemia. 6. During taking this product, avoid taking cholestamide, intestinal adsorbent and digestive enzyme preparations at the same time, so as not to affect the efficacy of this product.
Drug interactions: 1. If this product is used together with sulfonylurea drugs, metformin or insulin, blood sugar may drop to the level of hypoglycemia, you need to reduce the dose of sulfonylurea drugs, metformin or insulin. 2. While taking this product, avoid taking antacids, cholestyramine, intestinal adsorbents and digestive enzyme preparations at the same time, so as not to affect the efficacy of this product. 3. Taking neomycin at the same time can lower blood sugar after meal and aggravate gastrointestinal reaction of this product.
Pharmacological effects: This product is an oral hypoglycemic agent. The mechanism of its hypoglycemic effect is to inhibit the competition between small intestinal wall cells and oligosaccharides, and reversibly bind with α-glucosidase to inhibit enzyme activity, thereby delaying the degradation of carbohydrates, causing slow absorption of intestinal glucose and reducing meals. After the increase in blood sugar.
Storage: shading, sealed, in a cool place
Validity: 24 months
Manufacturer: Bayer Healthcare Co., Ltd.
Manufacturer Address: No. 7 Rongjing East Street, Beijing Economic and Technological Development Zone, Beijing
